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There are no reports about the clinical presentations and outcome of 
Guillain-Barré syndrome (GBS) in our region, therefore, we aimed to 
report some of the above mentioned finding a aforementioned findings in 
children diagnosed with GBS in Isfahan, central Iran. 
Materials & Methods
In this retrospective study, pediatric children diagnosed with GBS referred 
to Imam Hossein Hospital, the Pediatric Referral Center of Isfahan 
Province, central Iran were enrolled from 2011-2014. The following 
datar were extracted from the medical files of the patients; age, gender, 
early signs and symptoms of GBS, neurological features, sensory and 
motor and autonomic involvements, sphincter dysfunction, bulbar muscle 
involvement, respiratory failure, cranial nerve paralysis, delay time from 
onset to definite diagnosis, management of GBS, and the outcome. 
Results
Overall, 57 children with GBS aged 1-13 yr were evaluated. Frequency 
of GBS was significantly higher in boys than in girls (6.38% vs. 4.61%, 
P=0.01, OR=0.39). The most common clinical presentations were distal 
lower limb weakness (92.11%), reduced deep tendon reflex (DTR) 
(82.46%) and neuropathic pain (75.44%). 92.9% of patients had complete 
recovery. 
Conclusion
Distal lower limb weakness, reduced deep tendon reflex, and neuropathic 
pain are the main clinical presentation in children with GBS but in some 
patients, DTR may be normal or even exaggerated in early stages  of 
disease. Revising the diagnostic criteria for GBS may be necessary. 
Most of our patients had complete recovery. The only death was due to 
autonomic involvement. Autonomic dysfunction could be associated with 
catastrophic outcome and patients with this kind of  clinical presentations 
need critical care.
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Introduction
The Guillain-Barré syndrome (GBS) is an acute 
immune-mediated polyneuropathy considered as 
the most common causes of acute flaccid paralysis 
in healthy children (1, 2). An overall worldwide 
incidence rate of GBS has been reported as 1 to 
2 per 100000 per year (3). The rate ranges from 
1.5 to 3.4 per 100000 among Iranian population 
(4). Although the syndrome could occur in all age 
groups, it predominantly affects adult population. 
GBS is more frequent in children aged 1-5 yr. 
The syndrome is more prevalent among males 
than females (5, 6). GBS is thought to be an 
autoimmune disorder that results from T and B 
cell activated immune response to some preceding 
infectious agents such as Campylobacter 
jejuni, Cytomegalovirus, Epstein-Barr virus, 
Mycoplasma pneumoniae and HIV (7, 8). Due 
to molecular mimicry of such infections, they 
could have cross-reaction with peripheral nerve 
components including the myelin or the axon, 
which consequently forms different types of GBS. 
Some triggering factors such as immunization, 
surgery, trauma, and bone-marrow transplantation 
could have role in the pathogenesis of GBS (7-9).
Though results of different studies from various 
geographical regions have reported great variability 
regarding the epidemiology and clinical features 
of GBS, the most frequent clinical presentations 
of GBS in children are pain, progressive muscle 
weakness, and reduced deep tendon reflexes. In 
younger children aged less than 4 yr, the most 
common features are pain in the legs and refusal 
to walk (10-12).
Understanding the clinical presentation as well as 
epidemiology of GBS in each population could 
help us in better understanding of the pathogenesis 
of the disease, its risk factors, and prognosis (13). 
Moreover, evaluating the outcome of GBD could 
be effective in determining the disease-related 
morbidity and mortality and planning appropriate 
therapeutic plans.
There are no reports in this regard from Isfahan, 
central Iran, so we aimed to report clinical findings 
and outcome of children diagnosed with GBS from 
there.
Materials & Methods
In this retrospective study, pediatric patients 
diagnosed with GBS in Imam Hossein Hospital, 
the Pediatric Referral Center of Isfahan Province, 
central Iran from Sep 2011 to Sep 2014 were 
included.
Ethics Committee and Pediatrics Review Board of 
Isfahan University of Medical Sciences approved 
the protocol of this study.
The children were selected by census sampling 
method from those who fulfilled the diagnostic 
criteria for GBS (14) and were hospitalized in the 
hospital. A pediatric neurologist reviewed medical 
files of the patients and those with complete 
information or the possibility of contacting the 
patient or his family for complete information 
were included. Those with missing data or non-
cooperative parents were excluded.
The following information were extracted from 
the medical files of the patients; age, gender, 
early signs and symptoms of GBS, neurological 
features, sensory and autonomic involvements, 
sphincter dysfunction, bulbar muscle involvement, 
respiratory failure, cranial nerve paralysis, 
treatment modality and the outcome.
Statistical analysis
Data were analyzed using SPSS software (ver. 
22, SPSS (Chicago, IL, USA). The continuous 
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of 1-13 yr were evaluated. Characteristics of 
all studied population, frequency of different 
clinical presentations of GBS and their outcome 
are presented in Table 1. Frequency of GBS was 
significantly higher in boys than in girls (38.6% 
vs. 61.4%, P=0.01, OR=0.39). Male to female rate 
in the occurrence of GBS was 1.59 (35/22).
GBS was more prevalent among children aged less 
than 10 yr old (P<0.001, OR=27.19). The most 
and categorical variables were presented as mean 
(SD) and n (%), respectively. The continuous and 
categorical variables between and within studied 
groups were compared using Student’s t-test 
and Chi-square test, respectively. The level of 
statistical significance was set at P<0.05.
Results
Overall, 57 children with GBS within the age 
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stage of their illness.
Frequency of GBS according to gender and 
age groups are shown in Figure 1. Though the 
frequency of GBS syndrome occurrence was 
higher in boys than girls in younger age group, 
the differences between girls and boys were not 
statistically significant (P=0.51).
common clinical presentations were distal lower 
limb weakness (92.11%), reduced deep tendon 
reflex (82.46%) and neuropathic pain (75.44%).
In our study, 7(12.28%) and 3 (5.26%) of the 
patients had normal and increased deep tendon 
reflex in initial stage of disease respectively. All of 
them developed hyporeflexia or areflexia in later 
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Figure 1. Frequency of Guillain-Barré syndrome according to gender and age groups
Distribution of different clinical feature of GBS in 
boys and girls are shown in Figure 2. Frequencies 
of different clinical features of GBS were not 
significantly different between girls and boys. 
Fascial palsy was more prevalent among girls 
(P=0.07) and respiratory muscle involvement was 
more frequent presentation among boys (P=0.07).
According to our treatment protocol for patients 
with GBS, 53 patients with significant motor 
disability (nonambulant) had been treated with 
IVIG. Four cases with mild symptom preserved 
ambulation were discharged without any treatment.
Seven patients (5 of them needed prolonged 
mechanical ventilation) had received second 
course of IVIG. Two of this patient with severe 
disability were treated with plasmapheresis after 
first course of IVIG and again received IVIG after 
plasmapheresis. 
Electrophysiological study was performed for 49 
patients. Eighteen patients had axonal (7 sensory-
motor and 11 motors) and 31 demyelinating type 
of polyneuropathy. There was no significant 
correlation between initial presentation and results 
of electrophysiological study (P>0.05). For ethical 
considerations, ethical approval was issued by 
the Research the Isfahan University of Medical 
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GBS in children younger than 5 yr old (15, 16), 
while others reported higher rate in children aged 
5-10 yr (17, 18). Almost all of the studies have 
reported lower occurrence of GBS in children 
older than 10 yr old (15-18). Comparing with 
reports from different region of Iran, mean age of 
our patients was similar to previous studies in Iran 
(4, 19, 20).
Young children are more prone to the infections 
contributing to the pathogenesis of GBS. Another 
explanation is possibly the higher susceptibility of 
myelin to disintegration in younger children (17).
According , GBS frequently affect boys more than 
girls. Different rates of male to female ratio have 
been reported for GBS.the ratio in our study was 
1.59. It which was similar to that reported by other 
studies (4, 17-20).
Sciences (93-393586) and relevant authorities for 
this study
Discussion
We reviewed clinical presentations and outcome 
of all pediatric patients with GBS referred to 
our center. GBS is more common in boys and 
in children aged less than 10 yr old. The most 
common clinical presentations were distal lower 
limb weakness, reduced deep tendon reflex, and 
neuropathic pain. A high proportion of patients 
had complete recovery.
In our study, most of the patients were aged less 
than 10 yr old. Though patients in the 6-9 yr age 
group were higher than those aged less than 5 
yr old, the difference was not significant. Some 
studies in this field have reported higher rate of 
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Figure 2. Distribution of different clinical feature of Guillain-Barré syndrome in boys and girls
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The most common clinical presentations were 
distal lower limb weakness, reduced deep tendon 
reflex, and neuropathic pain, similar to another 
study (21), and those reported in Mashhad, Tabriz, 
and Tehran in Iran (4, 19, 20).
The proportion of children with atypical clinical 
presentation of GBS was high with a rate of 24.2% 
(19). 
In previous studies in Japan and Singapore, 13% 
and 10% of the patients with GBS had normal or 
increased DTR respectively (22, 23). In our study, 
7(12.29) and 3(5.26) of the patients had normal 
and exaggerated deep tendon reflex in initial 
stage of disease respectively. All of these patients 
developed hyporeflexia or areflexia in later stage 
of their illness. This finding suggests revising the 
diagnostic criteria for GBS. 
Reported range for cranial nerve involvement 
is 30%-46% (4, 21, 24). In our study, 26.3% of 
patients had cranial nerve involvement, bulbar 
weakness, followed by facial nerve and trigeminal 
palsy.
Our reported rate of cranial nerve palsy was similar 
to that reported in Korea (25), India (17) and Iran 
(19). It was lower than that of Tabriz (4) and 
Mashhad (21), but was higher than that of France 
(18).
The feature of cranial nerve palsy with 
predominance of bulbar nerves followed by facial 
nerve was similar to that reported in Mashhad 
(24) and Tabriz (4). Most studies reported that the 
involvement of facial nerve was more common 
than other cranial nerves (26).
Autonomic dysfunction is mainly manifested 
as abnormal sweating, sinus tachycardia, blood 
pressure instability, and pupillary abnormality 
(18). The frequency of autonomic dysfunction in 
our study was 8% that was lower than the rates 
reported by previous studies in both Iran and 
other countries (10, 20). The outcome of one case 
with this presentation was death, the only death 
among our patients. He had tachycardia, abnormal 
sweating, and blood pressure instability. The 
patient died due to recurrent uncontrollable cardiac 
arrhythmias. 
The risk of respiratory muscles involvement 
requiring ventilatory support is lower in children 
than adults (27). In our study, 8% of patients 
received ventilator support because of respiratory 
insufficiency. The rate was reported to be 35%, 
27%, 12% and 10.5% in deferent studies from 
India (17), Taiwan (28), France (18) and Tabriz 
(4), respectively. In a prospective multicenter 
study in Germany of the pations required artificial 
ventilation (29).
Sphincter dysfunction was reported in 5% of our 
studied population. The rate was 15.2% in the 
study in Tehran (19).
The prognosis of GBS in children is better than 
adults (18). In general, it has shorter clinical course 
with higher rate of complete recovery. Reported 
mortality rate for  GBS in pediatric population has 
been reported as 1%-2% (30). In this study, 92% 
of patients had complete recovery with a 1.8% 
mortality rate. Our findings were similar to most of 
the reported studies in France (18), Tabriz (4) and 
India (17). No death related to GBS was reported 
in Mashhad (20).
In this study, 5% of patients had incomplete 
recovery that was similar to that reported in India 
(17). The rate was lower than that reported (19) in 
Tehran with a rate of 27%. The main cause is higher 
rate of patients with a typical clinical presentation.
 The limitations of this study were lower sample
 size and missing data regarding the antecedent
illness preceding GBS.
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 In conclusion, clinical presentation of GBS in
 majority of the patients is similar to previous
 studies but despite current diagnostic criteria for
 GBS, in a significant portion of the patients, DTR
 may be normal or even increased in early course
 of disease. This finding suggests revising the
 diagnostic criteria for GBS. Most of the patients
 had favorable prognosis. The only death was due to
 uncontrollable cardiac tachyarrhythmia in a patient
 with autonomic nervous system involvement.
 Autonomic dysfunction could be associated with
 catastrophic outcome and patients with these
clinical presentations require critical care.
Results could be utilized as baseline data for better 
understanding of the characteristics of GBS in 
children and consequently better management of 
the disease as well as development of prognostic 
modeling score for our patients. It is also 
recommended to design prospective study in this 
field to achievemore reliable results.
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